BackReviva Pharmaceuticals Holdings Overview

Reviva Pharmaceuticals Holdings Goodwill

Latest goodwill for RVPH: $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Reviva Pharmaceuticals Holdings Goodwill History

Loading

Reviva Pharmaceuticals Holdings vs. peers: Goodwill Comparison

Loading

Reviva Pharmaceuticals Holdings Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Reviva Pharmaceuticals Holdings (RVPH) FAQ

Reviva Pharmaceuticals Holdings (RVPH) currently reports a goodwill of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Reviva Pharmaceuticals Holdings's goodwill history and peer comparisons.

Reviva Pharmaceuticals Holdings's goodwill changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Reviva Pharmaceuticals Holdings reported $0 in goodwill as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Reviva Pharmaceuticals Holdings, and consider following RVPH for alerts when major investors trade the stock.

Reviva Pharmaceuticals Holdings is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RVPH with unrelated industries.